Universitätsklinikum Hamburg-Eppendorf

🇩🇪Germany

Country: 🇩🇪Germany

Ownership: Subsidiary

Established: 1989-05-19

Employees: 1K

Market Cap: -

Website: http://www.uke.de

Clinical Trials

Diastolic Dysfunction and Interstitial Lung Edema in Septic Patients

Completed

Conditions: Sepsis
Lung Edema
Fluid Overload
Diastolic Dysfunction

First Posted Date: 2018-12-07

Last Posted Date: 2021-05-14

Lead Sponsor: Universitätsklinikum Hamburg-Eppendorf

Target Recruit Count: 83

Registration Number: NCT03768752

Locations: 🇩🇪
Universitätskrankenhaus Hamburg-Eppendorf, Hamburg, Germany

Facilitators and Barriers in Anorexia Nervosa - Treatment Initiation

Conditions: Anorexia Nervosa
Feeding and Eating Disorders of Childhood

Interventions: Other: No intervention

First Posted Date: 2018-10-19

Last Posted Date: 2020-11-13

Lead Sponsor: Universitätsklinikum Hamburg-Eppendorf

Target Recruit Count: 450

Registration Number: NCT03713541

Locations: 🇩🇪
Curtius-Clinic, Specialist Clinic for Psychosomatics and Psychotherapeutic Medicine, Bad Malente, Schleswig-Holstein, Germany
🇩🇪
Clinic Lüneburger Heide, Bad Bevensen, Germany
🇩🇪
Schön Clinic Roseneck, Prien am Chiemsee, Bavaria, Germany

and more 15 locations

Vision Assessment With the Quick Contrast Sensitivity Function (qCSF) Method in Healthy Controls and MS

Conditions: Multiple Sclerosis

First Posted Date: 2018-10-11

Last Posted Date: 2018-10-22

Lead Sponsor: Universitätsklinikum Hamburg-Eppendorf

Target Recruit Count: 200

Registration Number: NCT03703180

Locations: 🇩🇪
Institute of Neuroimmunology and MS, Hamburg, Germany

Study of Nivolumab Alone or in Combination With Ipilimumab as Immunotherapy vs Standard Follow-up in Surgical Resectable HNSCC After Adjuvant Therapy

Phase 3

Active, not recruiting

Conditions: Head and Neck Cancer

Interventions: Procedure: Surgical resection of primary tumor
Radiation: Adjuvant radio(-chemo)therapy
Drug: Neoadjuvant Nivolumab
Drug: Adjuvant Nivolumab
Drug: Adjuvant Nivolumab and Ipilimumab

First Posted Date: 2018-10-09

Last Posted Date: 2023-05-23

Lead Sponsor: Universitätsklinikum Hamburg-Eppendorf

Target Recruit Count: 276

Registration Number: NCT03700905

Locations: 🇩🇪
HELIOS Klinikum Erfurt GmbH, Erfurt, Thüringen, Germany
🇩🇪
Katholisches Marienkrankenhaus Hamburg, Hamburg, Germany
🇩🇪
Klinikum Bielefeld, Bielefeld, Nordrhein-Westfalen, Germany

and more 4 locations

Cyclophosphamide as Graft-versus-host Prophylaxis After Allogeneic Stem Cell Transplantation for Multiple Myeloma

Phase 2

Conditions: Multiple Myeloma

Interventions: Drug: Cyclophosphamide

First Posted Date: 2018-10-09

Last Posted Date: 2021-08-23

Lead Sponsor: Universitätsklinikum Hamburg-Eppendorf

Target Recruit Count: 37

Registration Number: NCT03700450

Locations: 🇩🇪
University Medical Center Hamburg-Eppendorf, Hamburg, Germany
🇩🇪
Universitätsklinikum Heidelberg, Heidelberg, Germany
🇩🇪
Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz, Germany

Homoarginine Supplementation in Patients After Stroke

Not Applicable

Conditions: Deficiency; Diet

Interventions: Other: placebo
Dietary Supplement: 125 mg L-homoarginine

First Posted Date: 2018-10-02

Last Posted Date: 2021-07-02

Lead Sponsor: Universitätsklinikum Hamburg-Eppendorf

Target Recruit Count: 500

Registration Number: NCT03692234

Locations: 🇩🇪
University Medical Center Hamburg, Hamburg, Germany

Evaluation of Metacognitive Training for Depression in Later Life (MCT-Silver)

Not Applicable

Completed

Conditions: Depression

Interventions: Behavioral: MCT-Silver
Behavioral: Cognitive Remediation

First Posted Date: 2018-10-01

Last Posted Date: 2021-10-19

Lead Sponsor: Universitätsklinikum Hamburg-Eppendorf

Target Recruit Count: 80

Registration Number: NCT03691402

Locations: 🇩🇪
University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Comparative Effectiveness Trial of Transoral Head and Neck Surgery Followed by Adjuvant Radio(Chemo)Therapy Versus Primary Radiochemotherapy for Oropharyngeal Cancer

Phase 4

Active, not recruiting

Conditions: Oropharyngeal Cancer

Interventions: Procedure: Resection
Drug: Chemotherapy
Radiation: Radiotherapy
Procedure: Salvage neck dissection

First Posted Date: 2018-10-01

Last Posted Date: 2023-05-17

Lead Sponsor: Universitätsklinikum Hamburg-Eppendorf

Target Recruit Count: 280

Registration Number: NCT03691441

Locations: 🇩🇪
Berlin Charité, Berlin, Germany
🇩🇪
Universitätsklinikum Hamburg Eppendorf, Hamburg, Germany
🇩🇪
Universität des Saarlandes, Homburg, Saarland, Germany

and more 17 locations

HaemoAdsorption Nach Reanimation An ECMO

Not Applicable

Conditions: Resuscitation
Inflammation
Multi-Organ Disorder
Cardiac Arrest

Interventions: Device: Hemoadsorption

First Posted Date: 2018-08-16

Last Posted Date: 2018-08-16

Lead Sponsor: Universitätsklinikum Hamburg-Eppendorf

Target Recruit Count: 40

Registration Number: NCT03632837

Locations: 🇩🇪
University Hospital Hamburg-Eppendorf, Hamburg, Germany

Humor Therapy and Distress After Allogeneic Stem Cell Transplantation

Not Applicable

Conditions: Allogeneic Hematopoietic Stem Cell Transplantation

Interventions: Behavioral: Humor therapy

First Posted Date: 2018-07-19

Last Posted Date: 2018-07-19

Lead Sponsor: Universitätsklinikum Hamburg-Eppendorf

Target Recruit Count: 126

Registration Number: NCT03593161

Locations: 🇩🇪
University Medical Center Hamburg-Eppendorf, Hamburg, Germany

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy